国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
15期
2302-2304
,共3页
大剂量%沐舒坦%食管癌%肺功能
大劑量%沐舒坦%食管癌%肺功能
대제량%목서탄%식관암%폐공능
high-dose%Ambroxol%Esophageal cancer%Lung function
目的 探讨大剂量沐舒坦在食管癌围手术期应用中的临床效果.方法 80例食管癌患者随机平均分为两组,实验组40例在围手术期使用大剂量沐舒坦治疗,对照组40例使用常规剂量沐舒坦.结果 对照组有1例失访;两组病例术后第1天呼吸功能均显著下降至术前的34.3%~42.6%,术后第3、第7、第14天呼吸功能逐渐恢复,最终能达到术前55.5%~82.5%,其中在术后第3及第7天实验组FEV%、第14天对照组VC%恢复优于对照组;肺功能不良事件发生率分别为7.5%(实验组)及10.3%(对照组),两组差异无统计学意义.结论 在食管癌围手术期使用大剂量沐舒坦能够促进术后肺功能恢复.
目的 探討大劑量沐舒坦在食管癌圍手術期應用中的臨床效果.方法 80例食管癌患者隨機平均分為兩組,實驗組40例在圍手術期使用大劑量沐舒坦治療,對照組40例使用常規劑量沐舒坦.結果 對照組有1例失訪;兩組病例術後第1天呼吸功能均顯著下降至術前的34.3%~42.6%,術後第3、第7、第14天呼吸功能逐漸恢複,最終能達到術前55.5%~82.5%,其中在術後第3及第7天實驗組FEV%、第14天對照組VC%恢複優于對照組;肺功能不良事件髮生率分彆為7.5%(實驗組)及10.3%(對照組),兩組差異無統計學意義.結論 在食管癌圍手術期使用大劑量沐舒坦能夠促進術後肺功能恢複.
목적 탐토대제량목서탄재식관암위수술기응용중적림상효과.방법 80례식관암환자수궤평균분위량조,실험조40례재위수술기사용대제량목서탄치료,대조조40례사용상규제량목서탄.결과 대조조유1례실방;량조병례술후제1천호흡공능균현저하강지술전적34.3%~42.6%,술후제3、제7、제14천호흡공능축점회복,최종능체도술전55.5%~82.5%,기중재술후제3급제7천실험조FEV%、제14천대조조VC%회복우우대조조;폐공능불량사건발생솔분별위7.5%(실험조)급10.3%(대조조),량조차이무통계학의의.결론 재식관암위수술기사용대제량목서탄능구촉진술후폐공능회복.
Objective To investigate the clinical efficacy of high-dose ambroxol during the perioperative period in esophageal cancer.Methods 80 patients with esophageal cancers were randomly divided into two groups.The study group (40 patients) received high-dose ambroxol,while the control group received normal dose ambroxol.Results One patient lost for follow-up in the control group.The respiratory function declined to 34.3% to 42.6% of the baseline on day one after surgery,gradually restored on days 3,7,and 14,and finally returned to 55.5% to 82.5%.The study group was superior to the control group in FEV% on days 3 and 7 and VC% on day 14 after surgery.There was no significant difference between the two group in adverse events of lung function (7.5% in the study group vs.10.3% in the control group).Conclusions High-dose ambroxol during the perioperative period of in esophageal cancer can accelerate the postoperative restoration of lung function.